Andrea Botticelli

Pubblicazioni

Titolo Pubblicato in Anno
Association between body composition parameters and treatment-related toxicities in patients with metastatic breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors CLINICAL NUTRITION 2025
Impact of Drug-Drug Interactions on Clinical Outcomes in Metastatic Melanoma Patients Treated With Combined BRAF/MEK Inhibitors: A Real-World Study PIGMENT CELL & MELANOMA RESEARCH 2025
Immunotherapy in recurrent/metastatic head and neck squamous cell carcinoma: PD-L1 and beyond PATHOLOGICA 2025
Process management method in head and neck cancer patient care DISCOVER ONCOLOGY 2025
Sarcopenia in Breast Cancer Patients: A Systematic Review and Meta-Analysis CANCERS 2024
PD-L1 testing in metastatic triple negative breast cancer: Results of an Italian survey TUMORI 2024
An Integrated Care Approach to Improve Well-Being in Breast Cancer Patients CURRENT ONCOLOGY REPORTS 2024
CD137+ and regulatory T cells as independent prognostic factors of survival in advanced non-oncogene addicted NSCLC patients treated with immunotherapy as first-line JOURNAL OF TRANSLATIONAL MEDICINE 2024
Real-World Outcomes of Trastuzumab Deruxtecan in Patients With HER2+ Metastatic Breast Cancer: The DE-REAL Study THE ONCOLOGIST 2024
Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis BMC CANCER 2024
Clinical implications of the Drug-Drug Interaction in Cancer Patients treated with innovative oncological treatments CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 2024
The role of CD73 in predicting the response to immunotherapy in head and neck cancer patients PATHOLOGY RESEARCH AND PRACTICE 2024
The multidisciplinary management of locally advanced rectal cancer EXPERT REVIEW OF ANTICANCER THERAPY 2024
Correction: Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis BMC CANCER 2024
Correction to: Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY study (npj Breast Cancer, (2024), 10, 1, (58), 10.1038/s41523-024-00657-z) NPJ BREAST CANCER 2024
Assessing risks and knowledge gaps on the impact of systemic therapies in early breast cancer on female fertility: A systematic review of the literature CANCER TREATMENT REVIEWS 2024
Exploring Genomic Biomarkers for Pembrolizumab Response: A Real-World Approach and Patient Similarity Network Analysis Reveal DNA Response and Repair Gene Mutations as a Signature CANCERS 2024
Neuroendocrine neoplasms of the breast: a multicenter retrospective Italian study MINERVA ENDOCRINOLOGY 2024
Pregnancy-associated breast cancer: a diagnostic and therapeutic challenge DIAGNOSTICS 2023
Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approach CANCER IMMUNOLOGY, IMMUNOTHERAPY 2023

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma